|
Volumn 46, Issue 7, 2008, Pages 2381-2383
|
Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a University Hospital
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
BETA LACTAM ANTIBIOTIC;
BETA LACTAMASE INHIBITOR;
CEPHALOSPORIN DERIVATIVE;
NAFCILLIN;
VANCOMYCIN;
BACTERIAL PROTEIN;
MECA PROTEIN, STAPHYLOCOCCUS AUREUS;
ADULT;
AGED;
ANTIMICROBIAL THERAPY;
ARTICLE;
BACTEREMIA;
BACTERIAL GENE;
BACTERIUM IDENTIFICATION;
CLINICAL ARTICLE;
FEMALE;
HUMAN;
MALE;
MECA GENE;
MORTALITY;
NONHUMAN;
PHARMACIST;
PRIORITY JOURNAL;
STAPHYLOCOCCUS AUREUS;
UNIVERSITY HOSPITAL;
ADOLESCENT;
CHILD;
DRUG EFFECT;
GENETICS;
INFANT;
ISOLATION AND PURIFICATION;
MICROBIOLOGY;
MIDDLE AGED;
PENICILLIN RESISTANCE;
PRESCHOOL CHILD;
STAPHYLOCOCCUS INFECTION;
TIME;
TREATMENT OUTCOME;
STAPHYLOCOCCUS AUREUS;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-BACTERIAL AGENTS;
BACTEREMIA;
BACTERIAL PROTEINS;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HOSPITALS, UNIVERSITY;
HUMANS;
INFANT;
MALE;
METHICILLIN RESISTANCE;
MIDDLE AGED;
PHARMACISTS;
STAPHYLOCOCCAL INFECTIONS;
STAPHYLOCOCCUS AUREUS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 49049105531
PISSN: 00951137
EISSN: None
Source Type: Journal
DOI: 10.1128/JCM.00801-08 Document Type: Article |
Times cited : (49)
|
References (4)
|